Norwegian University of Science and Technology
Trondheim, 7006, Norway
NCT Number: NCT01765816
Hypothesis: Exercise will reduce morbidity and mortality rates in an elderly population. The extent of reduction will be intensity dependent.
As part of the "Generation 100" study, this sub-study project will investigate the effect of exercise on blood volume, cardiopulmonary health and heart function in healthy aging. Objective is to determine the acute effect of one endurance training session on blood volume in healthy elderly. The working hypothesis is that one interval training session increases total blood volume by 10% in healthy elderly, and that there will be no change after moderate continuous training.
Looking for future studies?
Notify Me70 year–75 year
All sexes
Interventional
Not applicable
Trondheim, 7006, Norway
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 hours
carbon monoxide-rebreathing spirometry (Bayreuth, Germany)
Time frame: 24 hours
carbon monoxide-rebreathing spirometry (Bayreuth, Germany)
Norwegian University of Science and Technology
Other
Generation 100: How Exercise Affects Mortality and Morbidity in the Elderly: A Randomized Control Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03458793
Ageing, Behavior
Birmingham, United Kingdom
View Trial DetailsNCT01666340
Ageing, Behavior
Trondheim, Norway
View Trial DetailsNCT06805578
Ageing, Cognition Disorders
Singapore
View Trial DetailsNCT05740241
Ageing
Nice, France
View Trial Details